# Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm

Study · id `cardio:ct-nct01691313` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01691313](<https://clinicaltrials.gov/study/NCT01691313>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01691313

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

## Technical summary

Registry record NCT01691313. Randomized; quadruple masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2013-09 (actual). Results posted on 2015-12-22.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 104 participants (enrolled count; ClinicalTrials.gov record NCT01691313, source copy `cardio:ctgov-nct01691313-2015-12-22`, retrieved 2026-10-26)
- Start date: 2012-11 (registry gives no type) (ClinicalTrials.gov record NCT01691313, source copy `cardio:ctgov-nct01691313-2015-12-22`, retrieved 2026-10-26)
- Primary completion: 2013-09 (actual) (ClinicalTrials.gov record NCT01691313, source copy `cardio:ctgov-nct01691313-2015-12-22`, retrieved 2026-10-26)
- Completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01691313, source copy `cardio:ctgov-nct01691313-2015-12-22`, retrieved 2026-10-26)
- Results first posted: 2015-12-22 (ClinicalTrials.gov record NCT01691313, source copy `cardio:ctgov-nct01691313-2015-12-22`, retrieved 2026-10-26)
- Countries: Israel; Russia (ClinicalTrials.gov record NCT01691313, source copy `cardio:ctgov-nct01691313-2015-12-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01691313-2015-12-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm
- Acronym: COR-ART
- Condition: Symptomatic Atrial Fibrillation
- Condition: Atrial Flutter
- Intervention (Drug): Vanoxerine
- Intervention (Drug): Placebo
- Lead sponsor: Laguna Pharmaceuticals, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm (`cardio:pubmed-25684233`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0757320426091e38eac879e5d2009a208c980040ef7b38b70fe162701cbef8e2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
